136 results
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
patients with de novo IAs
I/C
systematic review and meta-analysis of existing de novo IA cohorts, initial IAs in the middle cerebral artery
O
de novo IAs
P
pacientes sometidos a cirugía
I/C
intervenciones con ejercicio, controlados
O
reducción de la sarcopenia
P
mujeres postmenopáusicas
I/C
uso de estrógenos
O
infección del tracto urinario sintomática
P
embarazadas con Covid-19
I/C
Covid-19, control
O
cesáreas, partos pretérmino, admisiones a la UCI neonatal
P
idosos
I/C
prevenção de quedas, não-prevenção
O
prevenção de quedas
P
severe AS patients
I/C
local anesthesia (LA) and general anesthesia (GA), LA vs. GA
O
30-day mortality, procedural time, new pacemaker implantation, total stay in the hospital, use of the vasoactive drug, intra-and postoperative complications and emergencies
P
NAFLD, elderly, pre-LT type II diabetes mellitus
I/C
de novo PTMS, other liver diseases
O
cardiovascular disease events
P
patients who received LA
I/C
Phentolamine injection after LA, placebo or sham
O
return of normal sensation
P
792 patients
I/C
literature search using Pubmed, Scopus/EMBASE, and the Cochrane Library databases, seven studies (n=792) in the meta-analysis
O
mean and 95th percentile of the incubation period